| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 1.3K | 13.2% | 17.6% |
| Total Income | 1.3K | 12.6% | 17.4% |
| Expenditure | 1.2K | 12.8% | 18.5% |
| PBT | 115.70 | 7.4% | 2.6% |
| Net Profit | 103.30 | 24.3% | 10.7% |
| OPM | 18.47% | 0.58pp | 1.83pp |
| NPM | 7.89% | 0.75pp | 2.48pp |
| EPS | 3.22 | 26.3% | 10.1% |
EPL Ltd Reports 17.6% Revenue Growth in Strong Quarter
14 May 2026 · 14 May, 11:11 pm
Summary
EPL Limited announced strong financial results for Q4 FY26 and the full fiscal year ended March 31, 2026, driven by strategic investments and broad-based growth. Q4 FY26 revenue soared 17.6% year-on-year to ₹13,005 mn, contributing to a full-year revenue of ₹47,631 mn, up 13% over FY25. The company's EBITDA margin for FY26 improved by 49 basis points to 20.4%, while full-year PAT (excluding exceptional items) grew 15% to ₹4,171 mn. The robust performance was fueled by record growth in the Beauty & Cosmetics segment and healthy recovery in Oral Care, alongside strategic initiatives in geographic diversification and sustainability.
Key Highlights
- 1
EPL Limited reported a robust Q4 FY26, with revenue surging 17.6% year-on-year to ₹13,005 mn, marking the company's strongest quarter.
- 2
For the full fiscal year FY26, the company delivered a revenue of ₹47,631 mn, representing a 13% increase over FY25.
- 3
EBITDA margin for Q4 FY26 stood at 20.2%, while the full fiscal year FY26 EBITDA margin improved by 49 basis points over FY25 to 20.4%.
- 4
Full-year Profit After Tax (PAT), excluding exceptional items, grew 15% to ₹4,171 mn, demonstrating superior bottom-line outcomes.
- 5
The Beauty & Cosmetics segment delivered exceptional growth of approximately 30% year-on-year, becoming larger than Oral Care in most key markets.
- 6
The company commissioned a new manufacturing plant in Thailand during FY26, strengthening its global manufacturing footprint.
- 7
Sustainable tube formats contributed 38% of total sales during the quarter, reflecting steady progress in customer adoption and sustainability leadership.
Management Comments
Hemant Bakshi
FY26 has been a defining year for EPL. Our strategic shift towards Beauty & Cosmetics is now clearly translating into results, with the segment delivering an exceptional ~30% growth during the year. Beauty & Cosmetics is now larger than Oral Care in most key markets, marking a clear shift toward a more balanced and diversified portfolio. As we look ahead to FY27 and beyond, we are more confident than ever in our ability to sustain our growth trajectory and create lasting value for all our stakeholders.
Informational and educational content only. Not investment advice.